The Accreditation Council for Continuing Medical Education¹s new policies, particularly its new definition of commercial interest, have garnered much controversy and raised a lot of questions within the CME community. Previously, commercial interest was defined as a company or companies that produce healthcare products or services, usually meaning pharmaceutical/biomedical companies. The new definition casts a wider net, also including companies that market healthcare products. The purpose ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the ACCME Sheds More Light on New Policies, you'll also gain access to exclusive premium content.

Already registered? here.